Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Moodys
Boehringer Ingelheim
AstraZeneca
Baxter

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 9,345,498

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,345,498
Title:Methods of controlling magnetic nanoparticles to improve vascular flow
Abstract: Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.
Inventor(s): Creighton; Francis M. (Richmond Heights, MO)
Assignee: Pulse Therapeutics, Inc. (St. Louis, MO)
Application Number:14/581,775
Patent Claims:see list of patent claims

Details for Patent 9,345,498

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Microbix Biosystems Inc. KINLYTIC urokinase For Injection 021846 1978-01-16 ⤷  Try it Free 2029-11-02
Genentech, Inc. ACTIVASE alteplase For Injection 103172 1987-11-13 ⤷  Try it Free 2029-11-02
Genentech, Inc. CATHFLO ACTIVASE alteplase For Injection 103172 2001-09-04 ⤷  Try it Free 2029-11-02
Chiesi Usa, Inc. RETAVASE reteplase For Injection 103786 1996-10-30 ⤷  Try it Free 2029-11-02
Genentech, Inc. TNKASE tenecteplase For Injection 103909 2000-06-02 ⤷  Try it Free 2029-11-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Harvard Business School
McKinsey
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.